JD Health International I... (JDHIF)
JD Health International Statistics
Share Statistics
JD Health International has 3.2B shares outstanding. The number of shares has increased by 0.32% in one year.
| Shares Outstanding | 3.2B |
| Shares Change (YoY) | 0.32% |
| Shares Change (QoQ) | 0.03% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 17.25 and the forward PE ratio is null. JD Health International's PEG ratio is 0.19.
| PE Ratio | 17.25 |
| Forward PE | n/a |
| PS Ratio | 1.23 |
| Forward PS | n/a |
| PB Ratio | 1.3 |
| P/FCF Ratio | 16.75 |
| PEG Ratio | 0.19 |
Enterprise Valuation
JD Health International has an Enterprise Value (EV) of 49.43B.
| EV / Sales | 0.85 |
| EV / EBITDA | 9.85 |
| EV / EBIT | 11.41 |
| EV / FCF | 11.53 |
Financial Position
The company has a current ratio of 3.77, with a Debt / Equity ratio of 0.
| Current Ratio | 3.77 |
| Quick Ratio | 3.39 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.06 |
| Interest Coverage | 180.47 |
Financial Efficiency
Return on Equity is 7.54% and Return on Invested Capital is 2.29%.
| Return on Equity | 7.54% |
| Return on Assets | 5.84% |
| Return on Invested Capital | 2.29% |
| Revenue Per Employee | $16,318,709.6 |
| Profits Per Employee | $1,167,745.23 |
| Employee Count | 3,564 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 7.68 |
Taxes
| Income Tax | 639.66M |
| Effective Tax Rate | 13.34% |
Stock Price Statistics
The stock price has increased by 6.6% in the last 52 weeks. The beta is 1.05, so JD Health International's price volatility has been higher than the market average.
| Beta | 1.05 |
| 52-Week Price Change | 6.6% |
| 50-Day Moving Average | 3.16 |
| 200-Day Moving Average | 3.15 |
| Relative Strength Index (RSI) | 100 |
| Average Volume (20 Days) | 4 |
Income Statement
In the last 12 months, JD Health International had revenue of 58.16B and earned 4.16B in profits. Earnings per share was 1.32.
| Revenue | 58.16B |
| Gross Profit | 13.31B |
| Operating Income | 1.48B |
| Net Income | 4.16B |
| EBITDA | 5.02B |
| EBIT | 4.8B |
| Earnings Per Share (EPS) | 1.32 |
Balance Sheet
The company has 22.63B in cash and 258.39M in debt, giving a net cash position of 22.37B.
| Cash & Cash Equivalents | 22.63B |
| Total Debt | 258.39M |
| Net Cash | 22.37B |
| Retained Earnings | -13.22B |
| Total Assets | 71.27B |
| Working Capital | 42.94B |
Cash Flow
In the last 12 months, operating cash flow was 4.33B and capital expenditures -46.35M, giving a free cash flow of 4.29B.
| Operating Cash Flow | 4.33B |
| Capital Expenditures | -46.35M |
| Free Cash Flow | 4.29B |
| FCF Per Share | 1.36 |
Margins
Gross margin is 22.88%, with operating and profit margins of 2.54% and 7.16%.
| Gross Margin | 22.88% |
| Operating Margin | 2.54% |
| Pretax Margin | 8.25% |
| Profit Margin | 7.16% |
| EBITDA Margin | 8.63% |
| EBIT Margin | 2.54% |
| FCF Margin | 7.37% |
Dividends & Yields
JDHIF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 5.8% |
| FCF Yield | 5.97% |
Analyst Forecast
Currently there are no analyst rating for JDHIF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 2.42 |
| Piotroski F-Score | 6 |